Amiodarone Treatment and Visual Prognosis;Visuelle Prognose bei Amiodaronbehandlung

Klinische Monatsblatter fur Augenheilkunde

Volumn 220, Issue 11, 2003, Pages 774-786

  Schmidt, Dieter ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Amiodarone; Anterior ischaemic optic neuropathy; Colour blue defect; Drug induced visual deterioration; Papilloedema; Toxic neuropathy of the optic nerve

Indexed keywords

ACETYLDIGOXIN; AMIODARONE; ANTIARRHYTHMIC AGENT; FLUOCORTOLONE CAPROATE; PHENPROCOUMON; PHENYTOIN;

ADULT; AGED; ANGIOGRAPHY; ARTICLE; CLINICAL ARTICLE; COLOR VISION DEFECT; COLOR VISION TEST; COMPUTER ASSISTED TOMOGRAPHY; DIFFERENTIAL DIAGNOSIS; EVOKED VISUAL RESPONSE; FEMALE; FOLLOW UP; HUMAN; ISCHEMIC OPTIC NEUROPATHY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OPHTHALMOSCOPY; PAPILLEDEMA; PROGNOSIS; TACHYCARDIA; VISUAL IMPAIRMENT;

AGED; AGED, 80 AND OVER; AMIODARONE; ANTI-ARRHYTHMIA AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FLUORESCEIN ANGIOGRAPHY; FOLLOW-UP STUDIES; HUMANS; LONG-TERM CARE; MALE; MIDDLE AGED; OPTIC DISK; OPTIC NERVE DISEASES; OPTIC NEUROPATHY, ISCHEMIC; PROGNOSIS; REMISSION, SPONTANEOUS; RISK FACTORS;

EID: 0346874417     PISSN: 00232165     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2003-44614     Document Type: Article

References (51)

1. Ahmad S. Amiodarone and reversible benign intracranial hypertension. Cardiology 1996; 87: 90
2. Aït Ali F, Grolleau-Raoux F, Arnaud B, Schmitt-Bernard CF. Amiodarone et œdème papillaire: problèmes physiopathogéniques à travers un cas. J Fr Ophtalmol 2003; 26: 182-186
3. Bartolucci JJ, Ibañez PL, Verdugo CJ, Fuentes R, Arriagada GG, Torres JM. Neuritis retrobulbar inducida por amiodarona. Caso clínico (Amiodarone induced retrobulbar neuritis. Report of one case). Rev Med Chil 1999; 127: 827-830
4. Belec L, Davila G, Bleibel JM, Azoulay A, Laloun L, Poisson M. Neuropathie optique bilatérale au cours d'un traitement prolongé par l'amiodarone. Ann Méd Interne (Paris) 1992; 143: 349-350
5. Besser R, Treese N, Bohl J, Goebel HH. Klinische, neurophysiologische und bioptische Befunde beim neurotoxischen Amiodaronesyndrom. Med Klin 1994; 89: 367-372
6. Bockhardt H, Drenckhahn D, Lüllmann-Rauch R. Amiodarone-induced lipidosis-like alterations in ocular tissues of rats. Graefe's Arch Clin Exp Ophthalmol 1978; 207: 91-96
7. Boghen DR, Glaser JS. Ischaemic optic neuropathy. The clinical profile and natural history. Brain 1975; 98: 689-708
8. Borruat FX, Regli F. Pseudotumor cerebri as a complication of amiodarone therapy. Am J Ophthalmol 1993; 116: 776-777
9. Burde RM. Optic disk risk factors for nonarteritic anterior ischemic optic neuropathy. Am J Ophthalmol 1993; 116: 759-764
10. Charness ME, Morady F, Scheinman MM. Frequent neurologic toxicity associated with amiodarone therapy. Neurology 1984; 34: 669-671
11. Chew E, Ghosh M, McCulloch C. Amiodarone-induced cornea verticillata. Can J Ophthalmol 1982; 17: 96-99
12. Cordon Lopez A, Muñoz Lopez A, Fernandez Jimenez S, Ruiz de Elvira MJ. Acute intracranial hypertension during amiodarone infusion. Crit Care Med 1985; 13: 688-689
13. D'Amico DJ, Kenyon KR, Ruskin JN. Amiodarone keratopathy. Drug-induced lipid storage disease. Arch Ophthalmol 1981; 99: 257-261
14. Dewachter A, Lievens H. Amiodarone and optic neuropathy. Bull Soc Belge Ophtalmol 1988; 227: 47-50
15. Eryilmaz T, Atilla H, Batioglu F, Günalp I. Amiodarone-related optic neuropathy. Jpn J Ophthalmol 2000; 44: 565-568
16. Feiner LA, Younge BR, Kazmier FJ, Stricker BH, Fraunfelder FT. Optic neuopathy and amiodarone therapy Mayo Clin Proc 1987; 62: 702-717
17. Fikkers BG, Bogousslavsky J, Regli F, Glasson S. Pseudotumour cerebri with amiodarone. J Neurol Neurosurg Psychiat 1986; 49: 606
18. Garrett SN, Kearney JJ, Schiffman JS. Amiodarone optic neuropathy. J Clin Neuro-ophthalmol 1988; 8: 105-110
19. Gerling J, Meyer JH, Kommerell G. Visual field defects in optic neuritis and anterior ischemic optic neuropathy: distinctive features. Graefe's Arch Clin Exp Ophthalmol 1998; 236: 188-192
20. Ghosh M, McCulloch CI. Amiodarone-induced ultrastructural changes in human eyes. Can J Ophthalmol 1984; 19: 178-186
21. Gittinger JW, Asdourian GK. Papillopathy caused by amiodarone. Arch Ophthalmol 1987; 105: 349-351
22. Gobbelé R, Dahlke C, Mull M, Schwarz M. Amiodaron-induzierte bilaterale Optikusneuropathie. Nervenarzt 1999; 70: 560-565
23. Gordon RN, Burde RM, Slamovits T. Asymptomatic optic disc edema. J Neuro-Ophthalmol 1997; 17: 29-32
24. Grogan WA, Narkun DM. Pseudotumour cerebri with amiodarone. J Neurol Neurosurg Psychiat 1987; 50: 651
25. Hayreh SS. Anterior ischemic optic neuropathy. V. Optic disc edema an early sign. Arch Ophthalmol 1981; 99: 1030-1040
26. Ikäheimo K, Kettunen R, Mäntyjärvi M. Visual functions and adverse ocular effects in patients with amiodarone medication. Acta Ophthalmol Scand 2002; 80: 59-63
27. Krieg P, Schipper I. Bilaterale Optikusneuropathie nach Amiodarone-Therapie. Klin Mbl Augenheilk 1992; 200: 128-132
28. Kristin N, Ulbig M. Akutes Papillenödem. 69-jähriger Patient mit bilateralem akutem Papillenödem. Ophthalmologe 2001; 98: 212-213
29. Leifert D, Hansen LL, Gerling J. Amiodaron-Optikusneuropathie: ein eigenständiges Krankheitsbild? Drei Patienten mit beidseitiger Optikusneuropathie. Klin Monatsbl Augenheilkd 2000; 217: 171-177
30. Lewalter T, Schrickel J, Shlevkov N, Lüderitz B. Kardiale Effekte von Amiodaron. Unter besonderer Berücksichtigung der QT-Verlängerung und des Torsade-de-pointes-Risikos. Dtsch Ärztebl 2002; 99: B1727-B1731
31. Macaluso DC, Shults WT, Fraunfelder FT. Features of amiodarone-induced optic neuropathy. Am J Ophthalmol 1999; 127: 610-612
32. Mäntyjärvi M, Tuppurainen K, Ikäheimo K. Ocular side effects of amiodarone. Surv Ophthalmol 1998; 42: 360-366
33. Mansour AM, Puklin JE, O'Grady R. Optic nerve ultrastructure following amiodarone therapy. J Clin Neuro-ophthalmol 1988; 8: 231-237
34. Nagra PK, Foroozan R, Savino PJ, Castillo I, Sergott RC. Amiodarone induced optic neuropathy. Br J Ophthalmol 2003; 87: 420-422.
35. Nazarian SM, Jay WM. Bilateral optic neuropathy associated with amiodarone therapy. J Clin Neuro-ophthalmol 1988: 8: 25-28
36. Palimar P, Cota N. Bilateral anterior ischaemic optic neuropathy following amiodarone. Eye 1998; 12: 894-896
37. Rizzo JF, Lessell S. Optic neuritis and ischemic optic neuropathy. Overlapping clinical profiles. Arch Ophthalmol 1991; 109: 1668-1672
38. Schmidt D, Richter T, Reutern GM von, Engelhardt R. Akute Durchblutungsstörungen des Auges. Klinische Befunde und Ergebnisse der Doppler-Sonographie der A. carotis interna. Fortschr Ophthalmol 1991; 88: 84-98
39. Schmidt D. Die Arteriitis temporalis Horton. Diagnose, Differenzialdiagnose, Therapie, Seite 159. St. Gallen, Schweiz: Elephas Buchverlag, 1995
40. Sedwick LA, Hedges TR, Newman NJ. Clinical challenges, Getting to the heart of visual loss: When cardiac medication may be dangerous to the optic nerves. Surv Ophthalmol 1992; 36: 366-372
41. Seemongal-Dass RR, Spencer SR. Bilateral optic neuropathy linked with amiodarone. Eye 1998; 12: 474-484
42. Speicher MA, Goldman MH, Chrousos GA. Amiodarone optic neuropathy without disc edema. J Neuro-Ophthalmol 2000; 20: 171-172
43. Sreih AG, Schoenfeld MH, Marieb MA. Optic neuropathy following amiodarone therapy. Pace 1999; 22: 1108-1110
44. Thystrup JD, Fledelius HC. Retinal maculopathy possibly associated with amiodarone medication. Acta Ophthalmol 1994; 72: 639-641
45. Tisdale JE, Follin SL, Ordelova A, Webb CR. Risk factors for the development of specific noncardiovascular adverse effects associated with amiodarone. J Clin Pharmacol 1995; 35: 351-356
46. Uebermuth CA, Gerke E. Zunächst einseitige, später beidseitige Optikopathie. Amiodaron als Ursache? Ophthalmologe 2002; 99: 470-473
47. Zandijcke M van, Dewachter A. Pseudotumour cerebri with amiodarone. J Neurol Neurosurg Psychiat 1986; 49: 1463-1464
48. Vorperian VR, Havighurst TC, Miller S, January CT. Adverse effects of low dose amiodarone: a meta-analysis. J Am Coll Cardiol 1997; 30: 791-798
49. Walsh FB, Hoyt WF. Clinical Neuro-Ophthalmology. Third Edition, Volume One, page 577. Baltimore: The Williams & Willdns Comp, 1969
50. Weber K, Tesnau R, Danielczyk MM, Welt R. Durch Amiodaron induzierte Optikusneuropathie: Ein Fallbericht. 98. Tagung Dtsch Ophthalmol Ges 21.-24.9.2000 Berlin. Ophthalmologe 2000; 97 (Suppl 1): 77
51. Wilson JS, Podrid PJ. Side effects from amiodarone. Am Heart J 1991; 121: 158-171